TGFB1 and neoplasm: TAMs also induce immunosuppression through secreting cytokines such as IL-10 and TGF-β to prevent tumor cells from being attacked by natural killer and T cells during progression and after recovery from chemotherapy or anti-tumor immune (40–42).